Literature DB >> 2579329

Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites.

A Nestorowicz, G W Tregear, C N Southwell, J Martyn, J M Murray, D O White, D C Jackson.   

Abstract

A number of peptides of the hemagglutinin (HA) of X-31 influenza virus have been synthesised. The amino acid sequences of some of these peptides represent regions of HA which have been postulated [Wiley et al., Nature, Lond. 289, 373-378 (1981)] to form the antigenic sites of this molecule. Animals were immunized with free peptide or peptide conjugated to a carrier and the resulting antisera examined for their capacities to bind to homologous peptide, whole HA, reduced and alkylated HA, and intact virus. Not all peptides examined in this way were immunogenic. Only antibodies raised against the C-terminus of HA1 peptide displayed binding to virus. This antiserum bound to the intact HA but not to the reduced and alkylated form of the molecule. These results raise questions as to the feasibility of using synthetic peptides of the influenza HA in short linear sequences to elicit neutralising antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579329     DOI: 10.1016/s0161-5890(85)80008-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  Protein antigenicity.

Authors:  M H Van Regenmortel
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

3.  Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Authors:  R A Ffrench; X L Tang; E M Anders; D C Jackson; D O White; H Drummer; J D Wade; G W Tregear; L E Brown
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Minimum requirements for immunogenic and antigenic activities of homologs of a synthetic peptide of influenza virus hemagglutinin.

Authors:  X L Tang; G W Tregear; D O White; D C Jackson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes.

Authors:  Matthias Mueller; Sandra Renzullo; Roxann Brooks; Nicolas Ruggli; Martin A Hofmann
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

6.  Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin.

Authors:  L E Brown; J M Murray; E M Anders; X L Tang; D O White; G W Tregear; D C Jackson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Peptides as antigens. Importance of orientation.

Authors:  T Dyrberg; M B Oldstone
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

8.  Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.

Authors:  Miriam Klausberger; Rupert Tscheliessnig; Silke Neff; Raffael Nachbagauer; Teddy John Wohlbold; Monika Wilde; Dieter Palmberger; Florian Krammer; Alois Jungbauer; Reingard Grabherr
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

9.  Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination.

Authors:  Upma Gulati; Wendy A Keitel; Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2007-07       Impact factor: 4.380

10.  Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.

Authors:  Joel R Haynes; Janet Cunningham; Adolph von Seefried; Michael Lennick; Robert T Garvin; Shi-Hsiang Shen
Journal:  Biotechnology (N Y)       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.